Skip to content

Study of effect mechanism of acupuncture at Siguan Point on improvement of brain function in Parkinson's disease and influence on delirium after deep brain stimulation

Study of effect mechanism of acupuncture at Siguan Point on improvement of brain function in Parkinson's disease and influence on delirium after deep brain stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000080
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Acupuncture intervention group:acupuncture at Siguan Point
Sham acupoint acupuncture group:Acupuncture at non-chnnal-non-acupoint
Acupuncture group:Acupuncture at the Siguan point is administered to Parkinson's disease patients undergoing deep brain electrical stimulation surgery
Control group:No acupuncture and moxibustion intervention for Parkinson's disease patients undergoing deep brain stimulation surgery

Sponsors

Tsinghua University Yuquan Hospital(Tsinghua University Integrated Traditional Chinese and Western Medicine Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for Parkinson's disease patients: a. Patients aged 45-75 with primary Parkinson's disease; b. The course of Parkinson's disease is 5 years or more; c. Hoehn Yahr (H-Y) stage is 2.5 or above in the "closed" state (not taking medication); d. UPDRS motion score = 30 in the "off" state; e. Good response to dopamine drugs, with an UPDRS motor score improvement rate of over 30% in acute levodopa experiments (experimental drug Madopar 250mg); f. Those who have a daily medication cut-off period of at least 6 hours, or experience serious movement complications such as abnormal movements, or who repeatedly adjust medication but still cannot effectively improve; g. Mini Mental State Examination (MMSE) score = 24 points; h. No contraindications for magnetic resonance imaging testing. 2. Inclusion criteria for healthy subjects: a. Age range of 45-75 years old, confirmed by health examination to have no organic or significant functional diseases; b. No family history of mental or neurological disorders; c. There were no physical abnormalities (such as headache, fever, cough, etc.) at the time of enrollment; d. Not taking excitatory drugs; e. No contraindications for magnetic resonance imaging testing.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for Parkinson's disease patients: a. I have undergone surgical treatments for Parkinson's disease other than deep brain electrical stimulation, such as stereotactic destruction, cell transplantation, gamma knife, etc; b. The 'closed' state has serious midline symptoms such as language disorders, swallowing difficulties, and balance disorders; c. There are contraindications for neurosurgery, such as cerebral infarction, hydrocephalus, cerebral atrophy, ventricular enlargement, sequelae of cerebrovascular disease, as well as cardiovascular and cerebrovascular diseases such as heart disease and severe thrombocytopenia; d. There are other accompanying diseases that require or have been implanted with pacemakers, defibrillators, cochlear implants, and other nerve stimulators; e. There are accompanying diseases that seriously affect health, such as tumors and severe abnormalities in liver and kidney function (indicators exceeding three times the normal value). 2. Exclusion criteria for healthy subjects: a. Breastfeeding, pregnancy, and menstrual women; b. Physical abnormalities (such as headache, fever, cough, etc.) occurred during the trial period; c. Unable to cooperate with the completion of this study.

Design outcomes

Primary

MeasureTime frame
Postoperative delirium incidence rate;CAM-ICU( Confusion Assessment Method-ICU);CAM(Confusion Assessment Method);

Secondary

MeasureTime frame
rSO2(cerebral oxygen saturation);PSQI(Pittsburgh Sleep Quality Index);BIS(bispectral index);MDS-UPDRS-I(movement disorder society-sponsored revision of the unified Parkinson's disease rating scale-I);MDAS(Memorial Delirium Assessment Scale);

Countries

China

Contacts

Public ContactMA Yu

Tsinghua University Yuquan Hospital(Tsinghua University Integrated Traditional Chinese and Western Medicine Hospital)

mayu@tsinghua.edu.cn13051461976

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026